Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics
MicrobiologyOpen · 2026-02 · 15 (1)
DOI: 10.1002/mbo3.70233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, online erschienen am 15.02.2026. Verfasst von Tianjiao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-Autoimmune Diseases of Hebei Province, Hebei U…. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, The Medical Scientific Research of Hebei Health Commission.
Abstract (Originalsprache)
The escalating prevalence of antibiotic resistance has become a major threat to the effectiveness of conventional antibiotics. Meanwhile, the development of novel antibiotics faces substantial challenges, including lengthy research cycles, high costs, and the rapid emergence of bacterial tolerance, making it difficult for new drugs to keep pace with bacterial evolution. In this context, molecular reversal strategies targeting antibiotic resistance genes have emerged as a promising avenue to overcome this impasse. Among them, the use of antibiotic adjuvants, agents that enhance the efficacy of existing antibiotics by inhibiting resistance gene function, preventing their horizontal transfer or modulating host defense has gained considerable attention. Furthermore, innovative approaches such as CRISPR‐Cas gene editing, photodynamic therapy, nanotechnology, and ecological competition strategies have shown great potential in reversing antimicrobial resistance. Collectively, these strategies offer novel insights into addressing the global crisis of antibiotic resistance, paving the way for more effective clinical interventions and ensuring the sustained efficacy of current antibiotic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Science, Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-Autoimmune Diseases of Hebei Province, Hebei University, Baoding, China.
Förderung
- Natural Science Foundation of Hebei Province
- The Medical Scientific Research of Hebei Health Commission
Zitieren
APA
Li, T., Zeng, F., Zhang, J., Zhang, Y., & Yin, W. (2026). Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics. MicrobiologyOpen, 15(1). https://doi.org/10.1002/mbo3.70233
Vancouver
Li T, Zeng F, Zhang J, Zhang Y, Yin W. Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics. MicrobiologyOpen. 2026;15(1). doi:10.1002/mbo3.70233
BibTeX
@article{Li2026,
author = {Li, Tianjiao and Zeng, Fei and Zhang, Jie and Zhang, Yuangong and Yin, Wenjuan},
title = {Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics},
journal = {MicrobiologyOpen},
year = {2026},
volume = {15},
number = {1},
doi = {10.1002/mbo3.70233}
}
EUVIMED